Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus.

× No keyword cloud information.

11 in total

Review 1. Current perspectives on glycopeptide resistance.

Authors: N Woodford; A P Johnson; D Morrison; D C Speller
Journal: Clin Microbiol Rev Date: 1995-10 Impact factor: 26.132

2. Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia.

Authors: C Y Liu; W S Lee; C P Fung; N C Cheng; C L Liu; S P Yang; S L Chen
Journal: Clin Drug Investig Date: 1996-08 Impact factor: 2.859

3. Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.

Authors: C Martin; P Bourget; M Alaya; A Sertin; C Atlani; K Ennabli; R Said
Journal: Antimicrob Agents Chemother Date: 1997-05 Impact factor: 5.191

4. Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model.

Authors: S B Duffull; E J Begg; S T Chambers; M L Barclay
Journal: Antimicrob Agents Chemother Date: 1994-10 Impact factor: 5.191

5. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.

Authors: R N Greenberg
Journal: Antimicrob Agents Chemother Date: 1990-12 Impact factor: 5.191

6. In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis.

Authors: E Löwdin; I Odenholt; O Cars
Journal: Antimicrob Agents Chemother Date: 1998-10 Impact factor: 5.191

7. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response.

Authors: B H Ackerman; A M Vannier; E B Eudy
Journal: Antimicrob Agents Chemother Date: 1992-08 Impact factor: 5.191

8. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.

Authors: A Kureishi; P J Jewesson; M Rubinger; C D Cole; D E Reece; G L Phillips; J A Smith; A W Chow
Journal: Antimicrob Agents Chemother Date: 1991-11 Impact factor: 5.191

9. Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.

Authors: E M Bailey; M J Rybak; G W Kaatz
Journal: Antimicrob Agents Chemother Date: 1991-06 Impact factor: 5.191

Review 10. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors: R N Brogden; D H Peters
Journal: Drugs Date: 1994-05 Impact factor: 9.546